R
Rolf Kåresen
Researcher at University of Oslo
Publications - 90
Citations - 4786
Rolf Kåresen is an academic researcher from University of Oslo. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 34, co-authored 86 publications receiving 4510 citations. Previous affiliations of Rolf Kåresen include The Breast Cancer Research Foundation & Oslo University Hospital.
Papers
More filters
Journal ArticleDOI
Different Gene Expression Patterns in Invasive Lobular and Ductal Carcinomas of the Breast
Hongjuan Zhao,Anita Langerød,Youngran Ji,Kent W. Nowels,Jahn M. Nesland,Robert Tibshirani,Ida R. K. Bukholm,Rolf Kåresen,David Botstein,David Botstein,Anne Lise Børresen-Dale,Stefanie S. Jeffrey +11 more
TL;DR: Over half of the ILCs differ from IDCs not only in histological and clinical features but also in global transcription programs, and the remaining I LCs closely resemble IDCs in their transcription patterns.
Journal ArticleDOI
Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer
Gro Wiedswang,Elin Borgen,Rolf Kåresen,Gunnar Kvalheim,J. M. Nesland,Hanne Qvist,Ellen Schlichting,Torill Sauer,Jan Janbu,T. Harbitz,Bjørn Naume +10 more
TL;DR: ITC in BM is an independent predictor of DDFS and BCSS, and a combination of several independent prognostic factors can classify subgroups of patients into excellent and high-risk prognosis groups.
Journal ArticleDOI
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Anita Langerød,Hongjuan Zhao,Ørnulf Borgan,Jahn M. Nesland,Jahn M. Nesland,Ida Rashida Khan Bukholm,Tone Ikdahl,Rolf Kåresen,Anne Lise Børresen-Dale,Anne Lise Børresen-Dale,Stefanie S. Jeffrey +10 more
TL;DR: TP53 mutation status and gene-expression based groups are important survival markers of breast cancer, and these molecular markers may provide prognostic information that complements clinical variables, according to an ongoing characterization and classification of the disease.
Journal ArticleDOI
Mutation of GATA3 in human breast tumors
Jerry Usary,Victor Llaca,Gamze Karaca,Shafaq Presswala,Mehmet Karaca,Xiaping He,Anita Langerød,Rolf Kåresen,Daniel S. Oh,Lynn G. Dressler,Per Eystein Lønning,Robert L. Strausberg,Stephen J. Chanock,Anne Lise Børresen-Dale,Charles M. Perou +14 more
TL;DR: GATA3 is an essential transcription factor that was first identified as a regulator of immune cell function as discussed by the authors, and it has been shown that GATA3 variants may contribute to tumorigenesis in ESR1-positive breast tumors.
Journal ArticleDOI
Pessimism as a predictor of emotional morbidity one year following breast cancer surgery.
TL;DR: The prevalence of and predictive factors for emotional morbidity one year following surgery, with special focus on dispositional optimism/pessimism, was examined in 165 women, newly diagnosed with breast cancer.